AMACX | NMAAX | AMACX / NMAAX | |
Total Expense Ratio | 1.52 | 0.79 | 192% |
Annual Report Gross Expense Ratio | 1.64 | 0.79 | 208% |
Fund Existence | 31 years | 31 years | - |
Gain YTD | -1.625 | -2.111 | 77% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 241M | 384M | 63% |
Annual Yield % from dividends | 2.35 | 3.34 | 71% |
Returns for 1 year | -1.31 | -0.72 | 183% |
Returns for 3 years | 2.08 | 4.65 | 45% |
Returns for 5 years | -4.75 | -1.99 | 239% |
Returns for 10 years | -2.66 | 7.68 | -35% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 8.40 | 0.05 | +0.58% |
Global X Genomics & Biotechnology ETF | |||
QQQY | 25.99 | 0.09 | +0.35% |
Defiance Nasdaq 100 Target 30 Income ETF | |||
VONV | 84.86 | 0.26 | +0.31% |
Vanguard Russell 1000 Value ETF | |||
IGOV | 42.84 | -0.11 | -0.26% |
iShares International Treasury Bond ETF | |||
UCO | 22.35 | -0.27 | -1.19% |
ProShares Ultra Bloomberg Crude Oil |